Montine KS - Search Results

1

Cognitive profile of LRRK2-related Parkinson's disease.

Srivatsal S, Cholerton B, Leverenz JB, Wszolek ZK, Uitti RJ, Dickson DW, Weintraub D, Trojanowski JQ, Van Deerlin VM, Quinn JF, Chung KA, Peterson AL, Factor SA, Wood-Siverio C, Goldman JG, Stebbins GT, Bernard B, Ritz B, Rausch R, Espay AJ, Revilla FJ, Devoto J, Rosenthal LS, Dawson TM, Albert MS, Mata IF, Hu SC, Montine KS, Johnson C, Montine TJ, Edwards KL, Zhang J, Zabetian CP. Srivatsal S, et al. Among authors: montine tj, montine ks. Mov Disord. 2015 Apr 15;30(5):728-33. doi: 10.1002/mds.26161. Epub 2015 Feb 4. Mov Disord. 2015. PMID: 25650144 Free PMC article.

2

Central nervous system lipoproteins in Alzheimer's disease.

Montine TJ, Montine KS, Swift LL. Montine TJ, et al. Among authors: montine ks. Am J Pathol. 1997 Dec;151(6):1571-5. Am J Pathol. 1997. PMID: 9403708 Free PMC article.

3

Catalysis of catechol oxidation by metal-dithiocarbamate complexes in pesticides.

Fitsanakis VA, Amarnath V, Moore JT, Montine KS, Zhang J, Montine TJ. Fitsanakis VA, et al. Among authors: montine tj, montine ks. Free Radic Biol Med. 2002 Dec 15;33(12):1714-23. doi: 10.1016/s0891-5849(02)01169-3. Free Radic Biol Med. 2002. PMID: 12488139

4

Dopamine thioethers: formation in brain and neurotoxicity.

Montine KS, Sidell KR, Zhang J, Montine TJ. Montine KS, et al. Among authors: montine tj. Neurotox Res. 2002 Nov-Dec;4(7-8):663-669. doi: 10.1080/1029842021000045435. Neurotox Res. 2002. PMID: 12709304

5

Pharmacologic suppression of neuronal oxidative damage and dendritic degeneration following direct activation of glial innate immunity in mouse cerebrum.

Milatovic D, Zaja-Milatovic S, Montine KS, Horner PJ, Montine TJ. Milatovic D, et al. Among authors: montine tj, montine ks. J Neurochem. 2003 Dec;87(6):1518-26. doi: 10.1046/j.1471-4159.2003.02120.x. J Neurochem. 2003. PMID: 14713307 Free article.

6

Advanced glycation endproduct precursor alters intracellular amyloid-beta/A beta PP carboxy-terminal fragment aggregation and cytotoxicity.

Woltjer RL, Maezawa I, Ou JJ, Montine KS, Montine TJ. Woltjer RL, et al. Among authors: montine tj, montine ks. J Alzheimers Dis. 2003 Dec;5(6):467-76. doi: 10.3233/jad-2003-5607. J Alzheimers Dis. 2003. PMID: 14757937

7

Suppression of longitudinal increase in CSF F2-isoprostanes in Alzheimer's disease.

Quinn JF, Montine KS, Moore M, Morrow JD, Kaye JA, Montine TJ. Quinn JF, et al. Among authors: montine tj, montine ks. J Alzheimers Dis. 2004 Feb;6(1):93-7. doi: 10.3233/jad-2004-6110. J Alzheimers Dis. 2004. PMID: 15004331

8

Isoprostanes and related products of lipid peroxidation in neurodegenerative diseases.

Montine KS, Quinn JF, Zhang J, Fessel JP, Roberts LJ 2nd, Morrow JD, Montine TJ. Montine KS, et al. Among authors: montine tj. Chem Phys Lipids. 2004 Mar;128(1-2):117-24. doi: 10.1016/j.chemphyslip.2003.10.010. Chem Phys Lipids. 2004. PMID: 15037157 Review.

9

Oxidized low-density lipoprotein is present in astrocytes surrounding cerebral infarcts and stimulates astrocyte interleukin-6 secretion.

Shie FS, Neely MD, Maezawa I, Wu H, Olson SJ, Jürgens G, Montine KS, Montine TJ. Shie FS, et al. Among authors: montine tj, montine ks. Am J Pathol. 2004 Apr;164(4):1173-81. doi: 10.1016/S0002-9440(10)63205-1. Am J Pathol. 2004. PMID: 15039206 Free PMC article.

10

Analysis of alpha-synuclein-associated proteins by quantitative proteomics.

Zhou Y, Gu G, Goodlett DR, Zhang T, Pan C, Montine TJ, Montine KS, Aebersold RH, Zhang J. Zhou Y, et al. Among authors: montine tj, montine ks. J Biol Chem. 2004 Sep 10;279(37):39155-64. doi: 10.1074/jbc.M405456200. Epub 2004 Jul 1. J Biol Chem. 2004. PMID: 15234983 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

110 results

Search Page

Filters